Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
760.23-
QQQ
704.370.46%
BTC/USD
76997.600.5103%
DIA
527.840.02%
GLD
395.980.19%
TLT
81.660.26%

Estrella Immunopharma Inc

ESLANASDAQ
Trade with Public
Trade with Public
$0.6915
-0.0335-4.62%
At close: Aug 31, 5:00 PM EST
$0.7051
-0.0199-2.74%
Pre-Market: 4:01 AM EST
OverviewNewsEarnings ForecastPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Estrella Immunopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Estrella Immunopharma (ESLA).

Price Target Range — 5 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$8Upside to Avg. PT+1034.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Feb 9, 2026D. Boral CapitalJason KolbertMaintainedBuy$8
Jan 28, 2026D. Boral CapitalJason KolbertPT CutBuy$16→$8
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $8 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $8 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Lowers Price Target to $8

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and lowers the price target from $16 to $8.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Estrella Immunopharma, Maintains $16 Price Target

D. Boral Capital analyst Jason Kolbert maintains Estrella Immunopharma (NASDAQ:ESLA) with a Buy and maintains $16 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved